KIMS files FY26 audited financials; revenue up 23%, PAT down 14%

Revenue Growth 20pctEbitda Margin CompressionExceptional ItemRelated Party TransactionsResults View source PDF Explain this filing

KIMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹767.10

prior close

₹769.50

announcement price

In-mkt

timing

Nifty Smallcap 250market+0.4%+1.2% vs market

Hospital peers, median of 25sector-0.4%+2.1% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Smallcap 250 and 2.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

+0.2

15m

-0.2

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7+0.4+1.2-0.4+2.1

Next day

+3.3+1.2+2.1-0.8+4.1

+3.0+1.8+1.1-0.7+3.7

+5.2+2.4+2.7-0.0+5.2

+5.0+3.2+1.7+1.3+3.7

+5.0+2.6+2.4+0.1+4.9

+3.5+2.4+1.1+0.7+2.8

15d

+5.4+1.8+3.7-0.4+5.8

+4.5+4.7-0.2+3.6+0.9

+4.4+5.9-1.5+4.0+0.4

-0.1+3.3-3.4+2.6-2.7

UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KIMS filed audited FY26 results. Revenue grew ~23% YoY to Rs 17,015M; PAT fell ~14% to Rs 2,607M. EPS at Rs 6.52. Auditor S.R. Batliboi gave unqualified opinion. Total borrowings nearly doubled to Rs 14,528M; Rs 4,692M in new loans advanced to subsidiaries (balance Rs 6,057M). No dividend declared.

Likely market impact

Strong revenue growth offset by higher finance costs, exceptional losses, and rising subsidiary funding; margin compression and debt buildup may weigh on returns.